Onderneming Onconova Therapeutics Inc Nasdaq
Aandelen
US68232V1089
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Oncology Therapeutics
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Fruchtman
PSD | President | 73 | 19-01-15 |
Mark Guerin
DFI | Director of Finance/CFO | 55 | 01-09-13 |
Meena Arora
CTO | Chief Tech/Sci/R&D Officer | - | 24-10-23 |
Victor Moyo
CTO | Chief Tech/Sci/R&D Officer | - | 24-10-23 |
Matthew Parris
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Marino
BRD | Director/Board Member | 74 | 01-07-15 |
Jack Stover
BRD | Director/Board Member | 69 | 23-05-16 |
Mary Shoemaker
BRD | Director/Board Member | 63 | 01-04-20 |
Steven Fruchtman
PSD | President | 73 | 19-01-15 |
Trafford Clarke
BRD | Director/Board Member | 66 | 19-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 25 301 009 | 21 604 002 ( 85,39 %) | 0 | 85,39 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,03% | 49,18 mld. | |
-0,10% | 42,11 mld. | |
+47,02% | 40,37 mld. | |
-5,26% | 28,85 mld. | |
+11,48% | 26,09 mld. | |
-22,74% | 18,71 mld. | |
+9,06% | 13,26 mld. | |
+30,01% | 12,32 mld. | |
-1,51% | 11,99 mld. |